Literature DB >> 18775353

Insulin resistance: the link between obesity and cardiovascular disease.

Gerald M Reaven1.   

Abstract

Insulin-mediated glucose disposal varies at least sixfold in apparently healthy individuals. The adverse effect of decreases in the level of physical fitness on insulin sensitivity is comparable to the untoward impact of excess adiposity, with each accounting for approximately 25% of the variability of insulin action. It is the loss of insulin sensitivity that explains why obese individuals are more likely to develop cardiovascular disease, but not all overweight/obese individuals are insulin resistant. At a clinical level, it is important to identify those overweight individuals who are also insulin resistant and to initiate the most intensive therapeutic effort in this subgroup. Finally, it appears that the adverse impact of overall obesity, as estimated by body mass index, is comparable to that of abdominal obesity, as quantified by waist circumference.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775353     DOI: 10.1016/j.ecl.2008.06.005

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  27 in total

1.  Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats.

Authors:  Alice Liu; Alper Sonmez; Gail Yee; Merlijn Bazuine; Matilde Arroyo; Arthur Sherman; Tracey McLaughlin; Gerald Reaven; Samuel Cushman; Philip Tsao
Journal:  Diab Vasc Dis Res       Date:  2010-10-20       Impact factor: 3.291

2.  Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women.

Authors:  April J Stull; Katherine C Cash; William D Johnson; Catherine M Champagne; William T Cefalu
Journal:  J Nutr       Date:  2010-08-19       Impact factor: 4.798

3.  Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk.

Authors:  Ruth Ann Bertsch; Maqdooda A Merchant
Journal:  Perm J       Date:  2015

4.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys.

Authors:  Ho-Won Lee; Ranganath Muniyappa; Xu Yan; Lilly Q Yue; Ellen H Linden; Hui Chen; Barbara C Hansen; Michael J Quon
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

5.  Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Authors:  Alice Liu; James Cardell; Danit Ariel; Cindy Lamendola; Fahim Abbasi; Sun H Kim; Tyson H Holmes; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

6.  Risk for obstructive sleep apnea in obese, nondiabetic adults varies with insulin resistance status.

Authors:  Alice Liu; Clete A Kushida; Gerald M Reaven
Journal:  Sleep Breath       Date:  2012-04-07       Impact factor: 2.816

7.  Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in a high-risk vascular cohort.

Authors:  Michel R Hoenig; Gary Cowin; Raymond Buckley; Christine McHenery; Alan Coulthard
Journal:  Nutr Metab (Lond)       Date:  2010-06-16       Impact factor: 4.169

8.  MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

9.  Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women--results from the Health, Aging, and Body Composition Study.

Authors:  Sari Stenholm; Annemarie Koster; Dawn E Alley; Denise K Houston; Alka Kanaya; Jung Sun Lee; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Marjolein Visser; Tamara B Harris; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-10-12       Impact factor: 6.053

10.  Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle.

Authors:  Cathryn M Kolka; L Nicole Harrison; Maya Lottati; Jenny D Chiu; Erlinda L Kirkman; Richard N Bergman
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.